<DOC>
	<DOCNO>NCT00021333</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining chemotherapy radiation therapy may make tumor cell sensitive radiation therapy . PURPOSE : Phase II trial study effectiveness paclitaxel cisplatin plus radiation therapy follow filgrastim treating patient recurrent head neck cancer lung cancer .</brief_summary>
	<brief_title>Paclitaxel Cisplatin Plus Radiation Therapy Followed Filgrastim Treating Patients With Recurrent Head Neck Cancer Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate patient locally recurrent carcinoma head neck lung treat paclitaxel cisplatin concurrent radiotherapy follow filgrastim ( G-CSF ) . II . Assess toxicity regimen patient . III . Determine time progression site pattern progression patient treat regimen . IV . Determine median , 1-year , 2-year survival rate patient treated regimen . OUTLINE : This multicenter study . Patients stratify accord disease ( squamous cell carcinoma head neck v salivary gland malignancy non-squamous cell carcinoma head neck v lung cancer ) . Patients receive paclitaxel IV 1 hour cisplatin IV 30-120 minute day 1-5 . Patients undergo radiotherapy twice daily day 1-5 . Patients receive filgrastim ( G-CSF ) subcutaneously day 6-13 blood count recover . Treatment repeat every 2 week total 4 course absence unacceptable toxicity disease progression . Patients follow every 2 month . PROJECTED ACCRUAL : A total 42-84 patient ( 14-28 per stratum ) accrue study within 2-4 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis 1 following : Previously irradiate , locally recurrent squamous cell carcinoma head neck ( SCCHN ) head neck skin/appendages distant metastasis New second subsequent primary SCCHN previously irradiate field distant metastases Salivary gland malignancy nonsquamous cell primary head neck cancer Previously irradiate , locally recurrent carcinoma lung No clinical evidence symptomatic bone brain metastasis require radiotherapy No leptomeningeal metastases require intrathecal therapy PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL SGOT great 3 time upper limit normal Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 60 mL/min Cardiovascular : No active , uncontrolled congestive heart failure arrhythmia within past 6 month Other : No preexist neuropathy grade 2 great interfere daily activity No prior allergy drug use Cremophor EL No hypersensitivity E. coliderived proteins No significant concurrent medical psychiatric disorder would preclude study No condition would preclude study Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception least 3 month study PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 4 week since prior chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics At least 3 month since prior radiotherapy Prior concurrent cumulative radiotherapy dose spinal cord great 5,000 cGy Surgery : Not specify Other : Concurrent betablockers , digitalis derivative , calciumchannel block agent allow cardiac condition stable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>recurrent thyroid cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent basal cell carcinoma lip</keyword>
	<keyword>recurrent verrucous carcinoma oral cavity</keyword>
	<keyword>recurrent mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>recurrent adenoid cystic carcinoma oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent lymphoepithelioma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent lymphoepithelioma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent verrucous carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
</DOC>